Biotech Appia Bio aims for a new kind of off-the-shelf CAR-T with $52M raise

Nobel Prizewinner David Baltimore, Ph.D. has always dreamed of turning Los Angeles into a biotech hub. He tried to help it along as president of the California Institute of Technology some 20 years ago, but the idea didn’t seem to stick. Now, he’s getting another crack at it with a new cancer cell therapy company co-founded with a group of Caltech and Kite Pharma alums.

Read more